149 related articles for article (PubMed ID: 38146732)
1. Clinical features of anti-pituitary-specific transcription factor-1 (PIT-1) hypophysitis: a new aspect of paraneoplastic autoimmune condition.
Urai S; Iguchi G; Kanie K; Bando H; Yamamoto M; Oi Y; Kashitani Y; Iida K; Kanzawa M; Fukuoka H; Takahashi M; Shintani Y; Ogawa W; Takahashi Y
Eur J Endocrinol; 2024 Jan; 190(1):K1-K7. PubMed ID: 38146732
[TBL] [Abstract][Full Text] [Related]
2. Two Cases of anti-PIT-1 Hypophysitis Exhibited as a Form of Paraneoplastic Syndrome not Associated With Thymoma.
Kanie K; Iguchi G; Inuzuka M; Sakaki K; Bando H; Urai S; Shichi H; Fujita Y; Matsumoto R; Suda K; Yamamoto M; Fukuoka H; Taniguchi T; Ogawa W; Takahashi Y
J Endocr Soc; 2021 Mar; 5(3):bvaa194. PubMed ID: 33506159
[TBL] [Abstract][Full Text] [Related]
3. A novel thymoma-associated autoimmune disease: Anti-PIT-1 antibody syndrome.
Bando H; Iguchi G; Okimura Y; Odake Y; Yoshida K; Matsumoto R; Suda K; Nishizawa H; Fukuoka H; Mokubo A; Tojo K; Maniwa Y; Ogawa W; Takahashi Y
Sci Rep; 2017 Feb; 7():43060. PubMed ID: 28216655
[TBL] [Abstract][Full Text] [Related]
4. Autoimmune Pituitary Disease: New Concepts With Clinical Implications.
Yamamoto M; Iguchi G; Bando H; Kanie K; Hidaka-Takeno R; Fukuoka H; Takahashi Y
Endocr Rev; 2020 Apr; 41(2):. PubMed ID: 31513261
[TBL] [Abstract][Full Text] [Related]
5. Paraneoplastic autoimmune hypophysitis: An emerging concept.
Bando H; Kanie K; Takahashi Y
Best Pract Res Clin Endocrinol Metab; 2022 May; 36(3):101601. PubMed ID: 34876362
[TBL] [Abstract][Full Text] [Related]
6. Paraneoplastic autoimmune hypophysitis: a novel form of paraneoplastic endocrine syndrome.
Takahashi Y
Endocr J; 2023 Jun; 70(6):559-565. PubMed ID: 37045779
[TBL] [Abstract][Full Text] [Related]
7. The early-stage clinical course of anti-pituitary-specific transcription factor-1 hypophysitis diagnosed post-immune checkpoint inhibitor treatment: A case with review of literature.
Urai S; Tomofuji S; Bando H; Kanzawa M; Yamamoto M; Fukuoka H; Tsuda M; Iguchi G; Ogawa W
J Neuroendocrinol; 2024 Apr; ():e13395. PubMed ID: 38631695
[TBL] [Abstract][Full Text] [Related]
8. [A Novel Clinical Entity "Anti-PIT-1 Antibody Syndrome"--Autoimmunity against a Transcription Factor].
Takahashi Y; Bando H; Iguchi G
Rinsho Byori; 2015 Apr; 63(4):491-7. PubMed ID: 26536783
[TBL] [Abstract][Full Text] [Related]
9. Adult combined GH, prolactin, and TSH deficiency associated with circulating PIT-1 antibody in humans.
Yamamoto M; Iguchi G; Takeno R; Okimura Y; Sano T; Takahashi M; Nishizawa H; Handayaningshi AE; Fukuoka H; Tobita M; Saitoh T; Tojo K; Mokubo A; Morinobu A; Iida K; Kaji H; Seino S; Chihara K; Takahashi Y
J Clin Invest; 2011 Jan; 121(1):113-9. PubMed ID: 21123951
[TBL] [Abstract][Full Text] [Related]
10. Autoimmune hypophysitis: new developments.
Takahashi Y
Handb Clin Neurol; 2014; 124():417-22. PubMed ID: 25248604
[TBL] [Abstract][Full Text] [Related]
11. A Novel Clinical Entity of Autoimmune Endocrinopathy: Anti-PIT-1 Antibody Syndrome.
Iguchi G; Bando H; Takahashi Y
Front Horm Res; 2017; 48():76-83. PubMed ID: 28245453
[TBL] [Abstract][Full Text] [Related]
12. The novel concept of "Onco-Immuno-Endocrinology" led to the discovery of new clinical entity "paraneoplastic autoimmune hypophysitis".
Takahashi Y
Best Pract Res Clin Endocrinol Metab; 2022 May; 36(3):101663. PubMed ID: 35525821
[TBL] [Abstract][Full Text] [Related]
13. Review on Recent Topics in Hypophysitis.
Sugihara H
J Nippon Med Sch; 2017; 84(5):201-208. PubMed ID: 29142180
[TBL] [Abstract][Full Text] [Related]
14. Mechanistic insights into immune checkpoint inhibitor-related hypophysitis: a form of paraneoplastic syndrome.
Kanie K; Iguchi G; Bando H; Urai S; Shichi H; Fujita Y; Matsumoto R; Suda K; Yamamoto M; Fukuoka H; Ogawa W; Takahashi Y
Cancer Immunol Immunother; 2021 Dec; 70(12):3669-3677. PubMed ID: 33977343
[TBL] [Abstract][Full Text] [Related]
15. Anti-PIT-1 antibody syndrome; a novel clinical entity leading to hypopituitarism.
Bando H; Iguchi G; Yamamoto M; Hidaka-Takeno R; Takahashi Y
Pediatr Endocrinol Rev; 2015 Mar; 12(3):290-6. PubMed ID: 25962206
[TBL] [Abstract][Full Text] [Related]
16. Unveiling the Etiopathogenic Spectrum of Hypophysitis: A Narrative Review.
Menotti S; Giampietro A; Raia S; Veleno M; Angelini F; Tartaglione T; Gaudino S; Doglietto F; De Marinis L; Pontecorvi A; Bianchi A; Chiloiro S
J Pers Med; 2023 Jul; 13(8):. PubMed ID: 37623461
[TBL] [Abstract][Full Text] [Related]
17. Recent insights into the pathogenesis of autoimmune hypophysitis.
Frasca F; Piticchio T; Le Moli R; Malaguarnera R; Campennì A; Cannavò S; Ruggeri RM
Expert Rev Clin Immunol; 2021 Nov; 17(11):1175-1185. PubMed ID: 34464545
[TBL] [Abstract][Full Text] [Related]
18. Involvement of PIT-1-reactive cytotoxic T lymphocytes in anti-PIT-1 antibody syndrome.
Bando H; Iguchi G; Fukuoka H; Yamamoto M; Hidaka-Takeno R; Okimura Y; Matsumoto R; Suda K; Nishizawa H; Takahashi M; Tojo K; Takahashi Y
J Clin Endocrinol Metab; 2014 Sep; 99(9):E1744-9. PubMed ID: 24937538
[TBL] [Abstract][Full Text] [Related]
19. In vivo and in vitro regulation of pituitary transcription factor-1 (Pit-1) by changes in the hormone environment.
González-Parra S; Chowen JA; García-Segura LM; Argente J
Neuroendocrinology; 1996 Jan; 63(1):3-15. PubMed ID: 8839350
[TBL] [Abstract][Full Text] [Related]
20. MECHANISMS IN ENDOCRINOLOGY: Autoimmune hypopituitarism: novel mechanistic insights.
Takahashi Y
Eur J Endocrinol; 2020 Apr; 182(4):R59-R66. PubMed ID: 31999621
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
